- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 307/14 - Radicals substituted by nitrogen atoms not forming part of a nitro radical
Patent holdings for IPC class C07D 307/14
Total number of patents in this class: 188
10-year publication summary
|
12
|
14
|
12
|
11
|
9
|
10
|
5
|
18
|
12
|
18
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Anavex Life Sciences Corp. | 74 |
21 |
| Mitsubishi Gas Chemical Company, Inc. | 3509 |
9 |
| Novartis AG | 10612 |
5 |
| Agios Pharmaceuticals, Inc | 217 |
5 |
| Archer Daniels Midland Company | 1129 |
5 |
| Genentech, Inc. | 4016 |
4 |
| BASF SE | 21098 |
3 |
| Janssen Pharmaceutica N.V. | 3358 |
3 |
| Sumitomo Chemical Company, Limited | 9109 |
3 |
| Wisconsin Alumni Research Foundation | 3894 |
3 |
| Chugai Seiyaku Kabushiki Kaisha | 1379 |
3 |
| Egis Gyogyszergyar Rt. | 54 |
3 |
| Taisho Pharmaceutical Co., Ltd. | 869 |
3 |
| Toyama Chemical Co., Ltd. | 99 |
3 |
| Sanofi | 4140 |
3 |
| Spirify Pharma Inc | 9 |
3 |
| Eccogene Inc. | 11 |
3 |
| F. Hoffmann-La Roche AG | 7937 |
2 |
| Hoffmann-La Roche Inc. | 3546 |
2 |
| Mitsui Chemicals, Inc. | 3230 |
2 |
| Other owners | 100 |